Allogeneic Transplantation for Myelofibrosis with Novel Graft-versus-Host Disease Prophylaxis

被引：0
|
作者：
Volodin, Leonid [1 ]
Ballen, Karen K. [1 ]
机构：
[1] Univ Virginia, Ctr Canc, Div Hematol Oncol, Charlottesville, VA 22908 USA
来源：
ACTA HAEMATOLOGICA | 2021年 / 144卷 / 02期
关键词：
D O I：
10.1159/000508198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [1] PHARMACOLOGICAL PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
    SCHWINGHAMMER, TL
    BLOOM, EJ
    CLINICAL PHARMACY, 1993, 12 (10): : 736 - 761
  • [2] Immunosuppressive therapy for prophylaxis of graft-versus-host disease in pediatric allogeneic stem cell transplantation
    Ozturk, Gulyuz
    Tagcu, Deniz
    Atay, Didem
    Akcay, Arzu
    Garipardyc, Mesut
    Anak, Sema
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 504 - 504
  • [3] Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation
    Chhabra, Saurabh
    Visotcky, Alexis
    Pasquini, Marcelo C.
    Zhu, Fenlu
    Tang, Xiaoying
    Zhang, Mei-Jie
    Thompson, Robert
    Abedin, Sameem
    D'Souza, Anita
    Dhakal, Binod
    Drobyski, William R.
    Fenske, Timothy S.
    Jerkins, James H.
    Rizzo, J. Douglas
    Runaas, Lyndsey
    Saber, Wael
    Shah, Nirav N.
    Shaw, Bronwen E.
    Horowitz, Mary M.
    Hari, Parameswaran N.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (10) : 1876 - 1885
  • [4] Ocular Graft-Versus-Host Disease After Allogeneic Transplantation
    Johnson, Natasha L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (06) : 621 - 626
  • [5] ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC MARROW TRANSPLANTATION
    PARKER, N
    COHEN, T
    NURSING CLINICS OF NORTH AMERICA, 1983, 18 (03) : 569 - 577
  • [6] Graft-versus-host disease in allogeneic transplantation: the good and the bad
    Kroeger, Nicolaus-Martin
    HAEMATOLOGICA, 2022, 107 (07) : 1494 - 1495
  • [7] Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis
    Morozova, Elena V.
    Moiseev, Ivan S.
    Barabanshikova, Maria V.
    Darskaya, Elena I.
    Bondarenko, Sergey N.
    Zubarovskaya, Ludmila S.
    Baykov, Vadim
    Alyanski, Alexandr L.
    Barkhatov, Ildar M.
    Zander, Axel R.
    Afanasyev, Boris V.
    BLOOD, 2017, 130
  • [8] Allogeneic Blood or Marrow Transplantation with Post Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma
    Ghosh, Nilanjan
    Ye, Xiaobu
    Tsai, Hua-Ling
    Bolanos-Meade, Javier
    Fuchs, Ephraim J.
    Luznik, Leo
    Swinnen, Lode J.
    Gladstone, Douglas E.
    Ambinder, Richard F.
    Varadhan, Ravi
    Shanbhag, Satish
    Brodsky, Robert A.
    Borrello, Ivan M.
    Jones, Richard J.
    Matsui, William
    Huff, Carol Ann
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1903 - 1909
  • [9] MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION - ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS
    KALHS, P
    BRUGGER, S
    SCHWARZINGER, I
    GREINIX, HT
    KEIL, F
    KYRLE, PA
    KNOBL, P
    SCHNEIDER, B
    HOCKER, P
    LINKESCH, W
    LECHNER, K
    TRANSPLANTATION, 1995, 60 (09) : 949 - 957
  • [10] Impact of including abatacept for graft-versus-host disease prophylaxis in allogeneic stem cell transplantation for hemoglobinopathy
    Shah, N.
    Sowa, A.
    Ngwube, A.
    Abraham, A.
    Anderson, E.
    Andreansky, M.
    Bhatia, M.
    Chaudhury, S.
    Cuvelier, G. D. E.
    Godder, K.
    Kamani, N.
    Jacobsohn, D.
    Gilman, A. L.
    Skiles, J.
    Dalal, J.
    Krajewski, J.
    Saini, S.
    Krishnamurti, L.
    Shenoy, S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 49 - 49
12345